Headache in SARS-CoV-2 infection

Takeaway

  • Headache in COVID-19 usually appears as an early symptom and is associated with a more benign disease course. Headache features were typical of an acute headache attributed to systemic viral infection.

Why this matters

  • Headache is an established symptom of COVID-19, reported in 13–74.6% of patients.

  • The neuroinvasive potential of SARS-CoV-2 is unclear. SARS-CoV-2 binds to ACE2 receptors which are not believed to be expressed in the central nervous system (CNS); however, key symptoms including headache, anosmia and ageusia, as well as the finding of SARS-CoV-2 in the cerebrospinal fluid in some patients, suggest the virus may nonetheless enter the CNS.

  • Many systemic viral infections are associated with headache, but it is possible that the headache seen in SARS-CoV-2 infection is distinct.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.